Introduction
Flat and depressed neoplastic lesions of the colorectum (Paris type [PT] II) 1 are now known to exist in Western populations [2] [3] [4] [5] [6] [7] . Two United Kingdom (UK) based studies have shown prevalence rates of between 22-38% in moderate to high risk colorectal cancer cohorts 4, 8 with the Sheffield group reporting high-grade dysplastic characteristics in 25% of flat lesions proximal to the hepatic flexure, data substantiated by Lanspa 9 , Smith 10 and Saito 5 . Endoscopic mucosal resection (EMR) for 'curative' intent is indicated for focal submucosal invasive neoplasia (submucosal-sm1) as lymph node metastasis (LNM) are rare 11, 12 . For PT II lesions vertically infiltrating sm layers 2 or 3, LNM rates exceed 10-15% 12 . Thus, for EMR specimens the 'cut off' value adopted by the Paris Workshop Group for quantitative micrometric measure is now assumed to be 1000µ 1 . The successful endoscopic management of early colorectal cancer (CRC) using EMR therefore requires the mandatory prediction of invasive depth estimation and LNM identification.
Previous studies have addressed the efficacy of high-magnification-chromoscopiccolonoscopy (HMCC) for the in vivo prediction of histopathological characteristics in PT type II lesions 2, [13] [14] [15] . However, while offering adequate sensitivities for the differentiation of hyperplasia from neoplasia, sensitivities when predicting grade of dysplasia and invasive depth have been variable. In Hurlstone's prospective analysis of sm invasion prediction 16 using the Nagata sub-classification 17 of the Kudo type V crypt pattern, 13 the kappa coefficient of agreement between crypt type V(a-c) and histologically confirmed sm invasion was 0.51 (95% CI). However, overall specificity was low at 50% with a tendency to over-stage lesions 16 . In the clinical context this reflects a high false positive rate for the anticipation of sm2+ disease, hence depriving some patients the opportunity of curative endoscopic resection.
In comparison to HMCC staging, endoscopic ultrasound (EUS) using the 7.5 MHz radial probe has encountered similar problems with T stage accuracy showing significant variability between groups (60-79%) 18, 19 . High-frequency ultrasound staging (HFUS) using the 20 MHz through the scope (TTS) mini probe has however shown superior T staging characteristics for PT type II lesions with Saito reporting a high overall accuracy of 88% 20 . Furthermore, Matsumoto demonstrated an overall accuracy of 91.8% and 63.3% for HFUS and HMCC respectively 21 .
Our aim was therefore to prospectively assess the clinical utility and staging accuracy of HFUS imaging for PT type II lesions as compared to HMCC Nagata criteria using standardised morphological, histopathological and HFUS imaging criteria. 
Methods

Study design
Each patient underwent a bi-phasic 'back to back' examination with lesions initially staged using HMCC (phase 1) followed by duel frequency 12.5 / 20 MHz TTS HFUS imaging (phase 2). Targeted chromoscopy using 5-10 ml of 0.5% indigo carmine (IC) was used to delineate detailed morphology 12 .
Lesions were classified morphologically according to the Paris Workshop guidelines 1 . Flat lesions were defined as mucosal change with a flat or slightly rounded surface with a height of less than half the diameter with no distinct stalk or pedicle (PT type II) 1 . Lesion diameter was estimated using a standard fully open biopsy forcep (4 mm) with the height estimated by placing a closed biopsy forcep tip adjacent to the lesion margin (2.1 mm) (Bard Inc, USA).
Following morphological classification using IC chromoscopy, all identified lesions underwent high-magnification imaging (x 100) using 0.05% crystal violet (CV) solution. CV was applied following normal saline lavage and removal of residual mucous residue by localised application of 5 ml N-acetycystine (2 mg/ml) using the Olympus PW5V-1 non-traumatic steel tipped catheter. Following a 'fixing phase' of 1-2 minutes any excess CV was aspirated using gentle suction prior to high-magnification imaging requisition. The surface pit pattern was subsequently classified according to the Nagata subclassification 17 of the Kudo type V crypt pattern 13 . Nagata grade A, B and C were defined as crypt disorder fully defined, crypt disorder partially defined and disorder non-defined or absent respectively 17 . The Nagata type C crypt was used as endoscopic criteria predictive of sm3, node positive disease 16, 17 .
Following HMCC all lesions underwent phase 2 HFUS imaging using the Olympus UM 2R 6 French 20 MHz and UM 3R 12.5 MHz TTS mini probe (Keymed, Southend-onsea). Acoustic coupling was achieved using the direct water immersion technique or by the distal balloon attachment method of Tseng 22 . Radial images were then acquired with invasion depth and nodal status classified according to Cho criteria 23 : uT0: lesions confined to the 1 st hypoechoic layer uT1: lesion penetration to the third hypoechoic layer uT2/3: lesion penetration of the muscularis propria (outer hypoechoic layer) or serosa (most peripheral echogenic band) uT4: lesion extension through the serosa with or without infiltration of adjacent structures u node positive (N+): presence of pericolic, well demarcated hypoechoic round or oval structures > 10 mm diameter.
Histopathology and resection practice
All identified lesions were cold biopsied, removed by EMR 2 or referred directly for surgical resection. Predicted T0/1/N0 lesions at HMCC or HFUS were resected using EMR (Roth net retrieval to minimise trauma and specimen fragmentation) with the remaining referred for surgical resection. An adjacent submucosal tattoo of Indian ink was applied to the latter group to enable operative localisation.
A single designated pathologist examined all specimens. Tissue was immediately fixed in 10% buffered formalin solution and subsequently stained with haematoxylin and eosin. Dysplasia was defined according to modified Vienna criteria as either low-grade (LGD) of high-grade (HGD) 24 . Invasive neoplasia was defined as neoplastic cellular proliferation extending into the sm layer 3 or beyond (> 1000µ) 24 . Early CRC was defined when intra or superficial sm carcinoma was present with no vertical extension into the sm layer 3 or muscularis 24 . The histopathological specimens were then compared to the HFUS and HMCC staging. Image capture All endoscopic procedures were digitally recorded in real-time using a Macintosh G4 PC interfaced with an analogue-digital PCX 540 transducer. With the aid of Macintosh Imovie software package (for Mac OsX) the entire digital video recording of the procedure was written to non-rewritable Sony CDQ74N2 650 MB compact disks in high quality large format Quick Time Player compatible mode. Further review of the endoscopic images of each procedure was thus permitted if required.
Statistical analysis
Statistical differences were analysed using the χ 2 tests of independence, Fisher's exact test, the Mann-Whitney U test and McNemar's test. A p value of less than 0.05 was considered statistically significant. The Bonferroni correction for multiple comparisons of data was applied where relevant. Calculations were made using the SPSS statistical package for Windows 1998 (Microsoft Corp USA). The University of Sheffield Statistics Unit provided statistical advice and support.
Results
A total of 53 patients with 53 PT type II lesions fulfilled inclusion criteria to the study (31 male, median age 63 years -range 41-79). One patient was excluded due to inadequate bowel preparation on two consecutive occasions. Five patients (9.6%) received conscious sedation using midazolam (median dose 2 mg; range 1-6). Intubation to the caecum and terminal ileum was possible in 51/52 patients (98%). One patient had received a previous right-hemi colectomy for Dukes 'A' carcinoma 3 years previouslyintubation to the neo-terminal ileum was achieved. There were no complications.
Twelve PT type II lesions were located in the caecum with 13,15,10 and 2 lesions located in the ascending, transverse, sigmoid colon and rectum respectively. Histopathologically, 12 (23%) PT class II lesions were restricted to the sm layer 1 with 13 (25%) and 27 (52%) involving the sm layer 2 and 3 respectively. The median lesion size was 8 mm (range 2-18). EMR inclusion criteria were met by 25 (48%) lesions with the remaining 27 (52%) being referred for surgical excision. Of the 25 lesions meeting EMR inclusion criteria, 8 (32%) were resected en bloc with 17 (68%) using a piecemeal approach. Cold biopsy sampling was performed in the remaining 27 lesions referred for direct surgical excision. Histological verification of lymph node status was therefore possible in 27 cases.
HMCC phase 1 T/N staging
High-magnification imaging and subsequent Nagata criteria 17 were obtained in all 52 lesions. Nagata class A, B and C crypt pattern was observed in 9/12 (75%), 8/13 (61%) and 13/27 (48%) of lesions with sm1, sm2 and sm3+ confirmed pT disease respectively. Seventeen lesions were staged as pN0 of which 8/17 (47%) were correctly staged using the Nagata type C crypt pattern as predictive of node positive disease. HMCC overstaged 9/17 (53%) lesions as tTN1 as compared to the actual pN0 status at histopathology. Of the 10 lesions staged as pN1, 4 (40%) were predicted as tTn1 disease with 6 (60%) being under-staged using HMCC as tTN0. Using the Nagata class C crypt pattern as a predictor of LNM yielded a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 0.31, 0.57, 0.4 and 0.47 respectively. The Kappa coefficient of agreement between Nagata class C crypt and LNM was 0.25 (95% CI -0.5 -0.26).
HFUS phase 2 T/N staging
Acoustic coupling was achieved in all 52 lesions (48 direct water couple / 4 balloon assisted). Twelve lesions were assessed using HFUS (uT) as sm1, 12 sm2 and 25 sm3+. When compared to the histopathological specimens, overall accuracy for sm1, sm2 and sm3+ was 100% (12/12), 92% (12/13) and 93% (25/27) respectively. Forty-nine lesions (94%) were correctly staged using HFUS when compared to the histopathological specimen. Of the remaining 3 lesions (6%), 1 caecal PT II lesion was under-staged as sm2 (pT sm3+/T2) with 2 ascending colonic PT II lesions under-staged as uT sm3 compared to the pT stage of T4 disease. Using Cho criteria 23 at HFUS as predictive of LNM sensitivity, specificity, PPV and NPV was 0.8, 0.88, 0.8 and 0.88 respectively. The Kappa coefficient of agreement between HFUS anticipated LNM was 0.68 (95% CI 0.4 -0.97).
The prevalence of nodal disease overall was 19% (10/52) with 80% (8/10) occurring in the sm3+ group. pN0 disease was observed in 17 (63%) of PT type II lesions of which 15 (88%) were correctly staged using HFUS. Eight lesions (8/10 -80%) were staged as uTN1 that were confirmed as pN1 post-operatively. Twenty percent (2/10) node positive lesions were however under-staged at HFUS. HFUS was significantly more sensitive at predicting both T and N stage as compared to HMCC (p < 0.0001 / p < 0.001) respectively. The correlation between Nagata endoscopic stage, HFUS stage and histopathology are summarised in tables 1 and 2. 
Discussion
This is the largest prospective study and the first in the UK to address the efficacy of HMCC and HFUS for the T and N staging of PT type II colorectal lesions performed by a single endoscopist. These data validate the retrospective analysis of Matsumoto et al from Japan
21
. Our data suggest that HFUS is superior to HMCC using the Nagata crypt sub-analysis 17 (conventionally considered to be the 'gold standard') for both invasive depth estimation and anticipation of LNM. Furthermore, we have demonstrated a significant association between deep submucosal invasion and the presence of lymph node metastasis as previously described by Japanese groups 11, 25 .
HMCC has now been shown by both Japanese and Western groups to provide an accurate in vivo tool to distinguish between neoplastic and non-neoplastic lesions of the colorectum 26, 27 . Kato's retrospective review of 3438 lesions 28 (classified according to modified Kudo criteria 13 ) showed diagnostic accuracy rates of 75%, 94% and 85% when distinguishing non-neoplastic lesions from adenoma and invasive carcinomas respectively. However, non-specified grade of dysplasia and the use of an adapted Vienna criterion for histopathological analysis make translation of these data to Western practice difficult. Using standardized morphological, crypt pattern and histopathological criteria, the Sheffield group subsequently demonstrated a sensitivity of 98% and specificity of 92% when distinguishing non-neoplastic from neoplastic lesions 2 . When differentiating neoplastic/non-invasive from neoplastic/invasive disease, sensitivity was poor (50%) with a specificity of 98% 2 . Hence, although providing the endoscopist with a useful tool to improve the diagnostic yield of significant lesions, while lowering the burden of insignificant histopathological sampling it cannot be used as a complete replacement for histopathology.
Few studies have addressed the use of HMCC as an in vivo staging tool for PT type II colorectal lesions where deep submucosal invasion has been associated with a higher risk of nodal disease (10-15%) 11, 29 . Endoscopic resection in this group is therefore potentially undesirable due to the risk of perforation (secondary to entrapment of the muscularis mucosa), non-curative excision and the risk of untreated nodal disease 12 . Nagata et al prospectively examined the efficacy of a novel sub-classification of the Kudo type V(n) crypt pattern and associated incidence of mucosal desmoplasis for PT type II lesions 17 . The incidence of sm2+ disease in this study was 38%, 94% and 100% for Nagata class A, B and C respectively 17 . However, despite this initial apparent 'high accuracy' data, other prospective validation studies have failed to reproduce these findings with reported poor specificity rates (50%) and a subsequent trend to over-stage lesions 16 . The use of chromoscopic colonoscopy without magnification imaging to establish discrete morphological characteristics favouring sm2+ disease, has been described by one other group 30 . Using Saitoh criteria (expansion appearance, present; surface depression, deep; irregularity of depressed surface, uneven; and converging fold toward the tumour) sensitivity and specificity rates were 90% 30 . A fall in specificity to 70% was however observed when lesions reported as 'intra mucosal' carcinoma were excluded from the analysis 30 . Thus, as the Nagata class C crypt 17 was the most commonly observed invasive pattern in our study we would suggest that Nagata C be adopted as an indication for subsequent HFUS imaging rather than an alternative staging modality. Previous studies from Japan have reported the efficacy of TTS HFUS for invasive depth estimation in PT type II colorectal lesions. Saitoh et al in a prospective analysis of 49 PT type II lesions using a 20 MHz TTS mini probe established diagnostic radial imaging in 76% of cases 20 . Overall accuracy of invasive depth using 20 MHz HFUS was 88% (43/49) (with reference to sm3 and the muscularis mucosa), 85% (11/13) for sm1 carcinoma and 100% (3/3) for intramucosal carcinoma 20 . However, invasive depth was incorrectly determined in 12% (6/49) of lesions 20 . This occurred in 3 cases due to insufficient acoustic coupling and in 2 cases due to an attenuated scanning range caused by an elevated G-type lesion morphology 20 . Furthermore, regional nodal disease was not established due to the limited depth of penetration using 20 MHz imaging.
In our study, acoustic coupling was achieved in all 52 (100%) lesions with 4 (7%) requiring the balloon assistance technique of Tseng 22 . This may in-part account for the improved scanning rates in our series. However, when comparing 'adjusted' HFUS imaging (excluding failed acoustic coupling) the overall accuracy rate for invasive depth estimation in our cohort was similar to those of Saitoh 20 and Tsuruta 31 (94%, 88%, 88.9% respectively).
Other studies have addressed the potential role of HFUS for nodal staging of colorectal carcinoma 32, 33 . 12.5 MHz HFUS imaging (using Cho criteria 23 ) to predict LNM in our series had a sensitivity of 0.8 with an NPV (lymph node negative prediction) of 0.88, data comparable with that of Tseng 22 , Hamada 34 and Hunerbein 35 . However, Stergio et al have reported lower sensitivity rates (56%) as compared to other groups 33 . In this series, 4/9 pN1 lymph nodes were not detected using HFUS 33 . Many reasons may account for the disparity in this data, including recently improved acoustic coupling using the Tseng balloon technique 22 , operator dependent error and the limited tissue penetration resultant from higher frequency imaging.
There are limitations to our study. All HMCC and HFUS imaging was performed by a single endoscopist. The absence of a 'blinded', single centre and operator design may therefore introduce bias error. Hence, application of these data to current clinical practice requires further validation using a prospective, randomised, double blind, multi-centre study design.
In conclusion, our data provides more evidence to suggest that TTS HFUS imaging is presently the most sensitive and specific tool for establishing both invasive depth and the presence of LNM for PT type II colorectal neoplasia. We have shown HFUS to be superior to HMCC alone (using modified Nagata criteria 17 ). However, our data suggests that HMCC may be complimentary to HFUS and provide important endoscopic criteria for further ultrasound imaging. Clinically, this is of paramount importance when selecting lesions suitable for endoscopic mucosal resection as opposed to surgical resection.
